To evaluate the toxicity and carcinogenic potential of long-term exposure to ozone, B6C3F1 mice were exposed by whole-body inhalation to 0, 0.12, 0.5, or 1.0 ppm and 0, 0.5, or 1.0 ppm ozone for 24 or 30 mo (lifetime), respectively. The incidence of alveolar/ bronchiolar adenomas and carcinomas (combined) increased (p < 0.05) in female mice exposed to 1.0 ppm for 24 or 30 mo and marginally increased (p > 0.05) in male mice exposed to concentrations of 0.5 or 1.0 ppm. An increased incidence of nonneoplastic lesions were observed in the nasal cavities and in the centriacinar region of the lung of mice exposed to 0.5 or 1.0 ppm for 24 and 30 mo. Nasal cavity lesions were mild and included hyaline degeneration, hyperplasia, squamous metaplasia, fibrosis and suppurative inflammation of the transitional and respiratory epithelium of the lateral wall, and atrophy of the olfactory epithelium. Lung lesions included replacement of the epithelium of the alveolar ducts and adjacent alveolar septa with epithelium similar to that normally found in terminal bronchioles (metaplasia) and associated alveolar histiocytosis. Based on the results of these studies, we conclude that inhalation exposure of B6C3F1 mice to ozone for 24 or 30 mo (a) is carcinogenic in female B6C3F1 mice exposed to 1.0 ppm of ozone based on an increased incidence of alveolar/bronchiolar adenoma or carcinoma and (b) results in mild, site-specific, nonneoplastic lesions in the nasal cavity and centriacinar lung of male and female mice exposed to 0.5 or 1.0 ppm of ozone for 2 yrs, which persist with continued exposure to 30 mo. It is uncertain whether or not the marginal increase (p > 0.05) of alveolar/bronchiolar neoplasms in male B6C3F1 mice resulted from exposure to ozone.
INTRODUCTION
Ozone is the principal oxidizing component in photochemical air pollution (smog) in many urban centers. More than 100 million people in the United States are exposed to ambient levels approaching 1.0 ppm, which exceeds the current National Ambient Air Quality Standard. (NAAQS). The current NAAQS is set at a maximum hourly average of 0.12 ppm, not to be exceeded more than once a year. Concentrations of ozone in the lower atmosphere vary depending on factors such as geographic location, time of day, local conditions, relative concentrations of reactants, and the degree of activation by sunlight (34, 35) . Available evidence suggests that exposure in heavily populated urban centers occurs as prolonged daily peaks lasting approximately 6-8 hr (34, 35) . Environmental levels that cause lung inflammation and alterations in pulmonary structure have been detected in urban centers (12, 30) . Transient concentration-related lung functional deficits occur among healthy exercising human subjects exposed for short or prolonged periods of time to concentrations at or below the current NAAQS (2, 16, 31, 47) .
In recent years, increasing concern over the health effects of oxidant air pollutants has stimulated considerable research (4, 7, 15, 30, 34, 35) . Consequently, extensive experimental data have been generated on the short-term toxic effects of ozone in the respiratory tract of rodents. However, its long-term toxicity and carcinogenic potential in rodents remains poorly defined. Several early studies suggested that ozone may be carcinogenic in the lungs of experimental animals (17, 32, 51) . More recent studies seemingly confirm the earlier reported carcinogenic effect in certain mouse strains. A slight increase in pulmonary adenomas was reported in A/J mice exposed to concentrations of 0.31 and 0.5 ppm ozone (23) . However, low numbers of mice were used in that study and the results were based only on lung neoplasms that were observed grossly. An increase in lung neoplasms was reported in A/J mice but not in Swiss-Webster mice exposed to 0.8 ppm ozone for 18 wk (33) . These studies also provided conflicting evidence that ozone may enhance (23) or inhibit (33) the development of chemically induced lung neoplasms in mice. In other species, ozone does not appear to be directly carcinogenic or to enhance the development of lung neoplasms. Increased incidences of lung neoplasms were not observed in Fischer-344 (F-344) rats exposed to ozone for 24 or 30 mo (4, 41) . Ozone did not enhance the development of lung neoplasms in F-344 rats or Syrian hamsters when simultaneously administered with a known carcinogen (4, 41, 52) .
Ozone was nominated for long-term toxicity/carcinogenicity testing in B6C3F1 mice and F-344 rats because of widespread human exposure and because of the lack of experimental data from well-controlled long-term rodent studies that could be used by regulatory agencies to set informed permissible standards for ozone exposure.
The initiative was a comprehensive collaborative effort by the National Toxicology Program (NTP), the Health Effects Institute, the Environmental Protection Agency (EPA), and various academic institutions. The studies in B6C3F1 mice, reported here, include (a) a 2-yr study in which mice were exposed to the current EPA standard (0.12 ppm), the maximum concentration considered compatible with long-term survival (1.0 ppm), and an intermediate concentration (0.5 ppm) and (b) a lifetime study in which the exposures at 0.5 and 1.0 ppm were extended to 30 mo. Lifetime exposures seemed prudent because the results of an earlier study in rats indicated that lung neoplasms may develop after 24 mo of inhalation exposure to diesel exhaust (36) .
MATERIALS AND METHODS
Study Design. In the 2-yr studies, groups of 50 male and 50 female mice were exposed to ozone at concentrations of 0.12, 0.5, or 1.0 ppm, 6 hr/day, 5 days/wk, for 105 wk. In the lifetime studies, groups of 50 mice of each sex were exposed to ozone concentrations of 0.5 and 1.0 ppm, 6 hr/day, 5 days/wk, for 130 wk. Concurrent control mice for each study (50 animals/sex) were exposed to filtered air for durations similar to those of the respective study. The studies were conducted in a facility at Battelle Pacific Northwest Laboratories accredited by the American Association for Accreditation of Laboratory Animal Care (AAALAC, Rockville, MD). The experimental protocol was approved by the Laboratories' Institutional Animal Use and Care Committee.
Animals. Male and female B6C3F1 mice were obtained from Simonsen Laboratories (Gilroy, CA) at 4-5 wk of age. After a quarantine period for health screening, the mice were randomly assigned to ozone exposure or control groups and were approximately 6-7 wk of age on the first day of exposure. The mice were housed individually in stainless-steel wire cages within modified min. Mean exposure concentration in the control chamber was 0.002 ppm (below the level of detection) and 0.12 ::!: 0.01, 0.51 -~-0.02, and 1.01 l ± 0.05 ppm (mean ± 1 SD) in the 0.12, 0.5, and 1.0 ppm chambers, respectively. Additional concentration data are provided in the NTP technical report (41) .
Tissue Preparation and Histological Evaluation. A complete necropsy and microscopic examination was performed on all mice found moribund or dead and on those that died at terminal sacrifices. Mice were sacrificed by 70% C02 asphyxiation followed by exsanguination. Samples of all major organs and tissues and all gross lesions were collected and immersed in 10% neutral-buffered formalin for fixation. The lungs were expanded to normal inspiratory volume and the nasal cavities flushed with fixative before immersion. All tissues were embedded in paraffin, sectioned at 5-6 /-1m, and stained with hematoxylin and eosin for histopathological examination. Coronal sections of the entire lung were prepared for histopathologic examination. The nasal cavity was sectioned transversely at 3 levels for examination: (a) the level of the incisor teeth, (b) midway between the incisor and the first molar teeth at the level of the incisive papilla, and (c) the middle of the second upper molar teeth. Statistical Analysis. Differences in survival were analyzed by life table methods (10) . Tumor incidence data were analyzed by survival-adjusted methods (22) and by Fisher's exact and Cochran-Armitage trend tests based on the overall proportion of mice bearing neoplasms (18) . These analytical methods were also used in the analyses of nonneoplastic lesions. The p-values reported for the comparisons of neoplasms are 1-sided.
RESULTS

Survival and Body Weights
Two-yr and lifetime survival rates for male and female mice exposed to ozone were not significantly different from those of the concurrent controls (Table I ). In addition, 2-yr survival rates of male or female mice did not differ significantly between the 2-yr and lifetime studies. Mean body weights of male mice exposed to 0.12 and TABLE I.-Survival of B6C3Fl mice exposed to ozone by inhalation for 2 yr or lifetime. 0.5 ppm were similar to those of controls throughout most of the 2-yr and lifetime studies (Table II and Fig.  1 ). However, the mean body weight of male mice exposed to 1.0 ppm was slightly lower than that of controls at the end of the 2-yr study. Compared to the concurreni controls, female mice exposed to 1 ppm of ozone for 2 yr or lifetime had a significant depression of mean body weight (p < 0.01) between 12 and 24 mo of exposure At the end of the lifetime study, the final mean body weights of exposed mice were not significantly different from those of the controls.
Nonneoplastic Lesions
Hyperplastic, metaplastic, and inflammatory lesion,, developed in the nasal cavity, larynx, and the lung oi ozone-exposed mice (Table III ). In general, a steep doseresponse effect was observed in the 2-yr studies; few le. sions occurred in mice exposed to 0.12 ppm, wherea! nearly all mice exposed to 0.5 or 1.0 ppm were affected The incidences of nonneoplastic lesions in the latter 1 TABLE II.-Comparison of mean body weights of B6C3F1 mice in 2-yr and lifetime inhalation studies of ozone at selected time points.
FIG. I.-Mean body weight curves for male and female B6C3Fl mice exposed to ozone for 2 yr (left panels) or lifetime (right panels). The mice were weighed weekly for the first 13 wk, at 4-wk intervals to week 92, and biweekly for the final weeks of the study. groups were similar; severities were greatest in mice exposed to 1.0 ppm. Similar nonneoplastic lesions were observed in the lifetime study; however, the severities did not appear to differ from those of the 2-yr study despite the additional months of exposure (Table III) .
Nonneoplastic lesions in the nasal cavity involved the transitional (cuboidal) epithelium lining the lateral walls in Levels I and II, including the lateral aspects and tips of the nasoturbinates and maxilloturbinates. Lesions included hyaline degeneration, hyperplasia and/or squamous metaplasia associated with minimal to mild fibrosis, and suppurative inflammation (Table III) . Respiratory and olfactory epithelial cells with hyaline degeneration contained variably sized, brightly eosinophilic cytoplasmic droplets that often filled and distorted affected cells (Fig.  2 ). Focal minimal to mild hyperplasia and squamous metaplasia occurred primarily along the ventrolateral aspects of the nasal cavity and at the tips of the turbinates. In hyperplastic sites, the thickness of the epithelium had increased from a single layer of pseudostratified epithelial cells to 3 or more layers of cuboidal cells, many of which had reduced numbers of cilia (Fig. 3 ). In areas of squamous metaplasia, normally ciliated epithelium was replaced by 3 or more layers of flattened cells. Both hyperplastic and metaplastic lesions were often accompa-nied by mild increases in fibrous tissue in the underlying submucosa. Suppurative inflammation occurred as small focal collections of neutrophils within the hyperplastic and metaplastic epithelium and the submucosa.
Focal, minimal to mild olfactory epithelial atrophy also occurred in dorsolateral sites of the ethmoid turbinates in Level III and, less commonly, in Level II of the nasal cavity. In both studies, the incidence was greatest in male and female mice exposed to 1.0 ppm; however, a greater response was observed in female mice (Table III) . Olfactory epithelial atrophy was characterized by reduction in the thickness of the epithelium from 5 to 6 cell layers to 1 or 2 layers of cuboidal cells due to the loss of olfactory neuronal cells ( Fig. 4 ). Atrophic lesions were frequently accompanied by an accumulation of a homogenous pale eosinophilic fluid in the adjacent nasal passages. Minimal hyperplasia and squamous metaplasia of the laryngeal epithelium were observed at the base of the epiglottis. The incidences of epithelial hyperplasia in this region of the larynx were significantly increased in female mice exposed to 1.0 ppm of ozone for 2 yr and in male and female mice exposed to 1.0 ppm for lifetime.
In the lifetime studies, the incidences of squamous metaplasia were significantly increased in male and females mice exposed to 1.0 ppm ozone. TABLE IIL-Incidence of nonneoplastic respiratory tract lesions in B6C3Fl mice exposed to ozone by inhalation for 2 yr or lifetime. In the lung, the primary exposure-related nonneoplastic lesions observed were restricted to the centriacinar region, which includes the terminal bronchioles, alveolar ducts, and proximal alveoli. The normally flattened epithelium of alveolar ducts and adjacent alveoli was replaced by cuboidal nonciliated and occasionally ciliated cells similar to those lining the terminal bronchioles (Fig.  5 ). This alteration was diagnosed as alveolar/bronchiolar epithelial metaplasia and appeared to represent an extension or downgrowth of the distal bronchiolar epithelium into the alveolar ducts. Minimal interstitial fibrosis was infrequently associated with the metaplastic lesions. Neoplastic Lesions A dose-related increased incidence of lung neoplasms occurred with increasing ozone exposure (Table IV ). In the 2-yr study, the most prominent increases were those of carcinomas in female mice exposed to 1.0 ppm and adenomas in male mice exposed to 0.5 and 1.0 ppm. The increases were also reflected in the combined incidences of adenomas or carcinomas, which were marginally increased (p < 0.15) in male mice exposed to 0.5 and 1.0 ppm and significantly increased (p < 0.05) in female mice exposed to 1.0 ppm. The increase in lung neoplasms in female mice exposed to 1.0 ppm exceeded the current NTP historical control values for inhalation studies (historical control lung neoplasm rates: males-150/673, 22 .3%, range 10-42%; females-58/659, 8.8%, range 0-15%). In the lifetime study, the incidence of carcinomas in exposed male mice was significantly greater (p < 0.01) than that of controls; however, the incidence of carcinomas was not increased in female mice. The incidence of adenomas in female mice exposed to 1.0 ppm was significantly greater (p < 0.05) than that of controls. The incidence of alveolar/bronchiolar adenomas and carcinomas (combined) were marginally increased (p < 0.15) in male mice exposed to 0.5 and 1.0 ppm and in female mice exposed to 1.0 ppm (p < 0.01). In addition, there was a slight increase (not significant) in the incidence of multiple carcinomas in exposed male mice (control = 2/49; 0.5 ppm = 5/49; 1.0 ppm = 4/50). Table V shows the combined analyses of the incidences of lung neoplasms in the 2-yr and lifetime studies and the prevalence of lung neoplasms over time. When the incidences were considered together, the significance increased, especially in female mice exposed to 1.0 ppm. Whereas the incidences of lung neoplasms were increased in exposed mice, the time-to-death with a lung neoplasm did not differ significantly. In all groups, the median time-to-death with lung neoplasms was approximately the 2-yr sacrifice.
In general, alveolar/bronchiolar adenomas and carcinomas that developed in control and ozone-exposed mice were morphologically and phenotypically similar. Adenomas were discrete masses that distorted or obliterated the underlying alveolar architecture and partially or completely compressed the adjacent alveolar parenchyma (Fig. 6 ). Most were well-differentiated masses composed of cuboidal to low columnar cells arranged in a papillary pattern with focal areas of dysplastic growth character- ized by disorganized piling up of cells. Others were sheets of polygonal cells (solid pattern) that were sometimes mildly atypical varying in size and with mild nuclear pleomorphism. A few adenomas had both papillary and solid (mixed) growth patterns. Carcinomas tended to be larger, expansive and invasive masses that frequently replaced entire lung lobes (Fig. 7 ). Most carcinomas had either papillary or mixed growth patterns, but a few carcinomas with a solid pattern were also observed. The degree of cellular atypia within carcinomas was variable.
DISCUSSION
Millions of people in large urban centers in the United States and around the world are exposed to ambient levels of ozone that approach or exceed the national standard (0.12 ppm) for permissible levels of exposure during severe smog episodes. Yet prior to this study, there was relatively little experimental data from animal studies that could be used to address potential long-term effects on human health. The present 2-yr and lifetime (30-mo) studies were designed to determine whether or not longterm exposure of B6C3F1 mice to ozone would result in j~ p = 0.06 vs controls.
FIG. 6.-Alveolar/bronchiolar adenomas in B6C3F1 mice exposed to ozone for 2 yr. a) Papillary pattern. Cuboidal neoplastic cells form papillary structures that efface the alveolar architecture. Male, 0.5 ppm. either toxicity or carcinogenicity. The lifetime study was included because recent inhalation toxicity/carcinogenicity studies of diesel exhaust suggested that an increase in treatment-related lung neoplasms may develop after 2 yr of exposure (36) .
Concentrations of ozone (ppm) ranging from those found in urban environments to higher concentrations still occasionally found in urban areas were used to study the toxic effects of long-term ozone exposure. In 4-wk NTP studies, the mice were able to tolerate 1.0 ppm without life-threatening toxic effects (41) . In the present studies, survival in the exposed groups was generally similar to that of the controls. There was, however, a 5-10% decrease in body weight of mice exposed to 1.0 ppm and the nearly 100% incidence of pulmonary and nasal lesions suggest that concentrations higher than 1.0 may not have been tolerated.
The respiratory tract is the principal target for ozone toxicity with effects manifested primarily in the nasal cavity and lung. Exposure to ozone causes a variety of toxic effects in the respiratory tract of laboratory animals (5, 15, 17, 32, 33, 45, 48) . All species studied generally respond to inhaled ozone in a similar manner despite interspecies physiological and anatomical differences in the respiratory tract. Lesions produced are morphologically similar; however, quantitative differences are demonstrable. The bronchiolar/alveolar (centriacinar) region of the lung is reported to be one of the most sensitive sites for ozone-induced toxicity in several species studied to date. Injury to this site is potentially more detrimental to pulmonary homeostasis and function than any other site in the respiratory tract. Rodents and monkeys acutely exposed to concentrations of ozone as low as 0.2 ppm develop pulmonary alterations characterized by inflammation, degeneration, necrosis, and proliferation of airway epithelium (7, 11) . Injury is primarily to the ciliated epithelium of the conducting airways and Type I pneumocytes of the alveoli. It is characterized by loss of cilia, flattening and/or loss of epithelium in the terminal bronchioles, degeneration of Type I pneumocytes, influx of alveolar macrophages and neutrophils, and ultimately, reorganization of the epithelium at the bronchiolar/alveolar junction (1, 5, 15, 19, 38, (42) (43) (44) . With continued exposure, much of the inflammatory response subsides. In the 2-yr study, the distribution and morphology of lesions observed in the respiratory tract of exposed mice were consistent with those observed in previous studies of shorter duration (5, 15, 45) . Lesions developed in the nasal cavity and at the bronchiolar/alveolar junction. Metaplasia of the epithelium of the alveolar ducts and proximal alveoli occurred in the majority of mice exposed to 0.5 and 1.0 ppm and few mice exposed 0.12 ppm and was frequently accompanied by minimal to mild alveolar histiocytosis. These lesions persisted with continued exposure to 30 mo but did not progress.
Ozone is absorbed along the entire length of the respiratory tract. Its absorption and the extent of lesions depend on the concentration of ozone, respiratory flow rate, and thickness of the protective mucus layer. Increasing the concentration of inhaled ozone results in lesion; at more distal sites. Much of the inhaled concentration i~r emoved in the nasopharynx (53) . In the lower respiratory tract, absorption and tissue dose are low in the trachea, maximum in the centriacinar region where the protective effect of the mucus or surfactant layers is minimal, and decrease rapidly thereafter, in the peripheral lung (39) . The distribution of nonneoplastic lesions in this study is consistent with the absorption patterns of ozone in the lung. The principal ozone-related damage occurred in the anterior nasal cavity and centriacinar region of the lung with minimal effects in more distal or peripheral alveoli. In both the 2-yr and lifetime studies, increasing the concentration of ozone resulted in a slight increase in the severity of nonneoplastic lesions. However, the severity of lesions did not appear to be appreciably affected by prolonged (lifetime) exposure in any of the exposure groups, an indication that perhaps some adaptation may have occurred.
The nasal cavity receives the highest concentrations of ozone during inhalation. In the 2-yr study, focal hyperplasia, hyaline degeneration, and squamous metaplasia occurred in the transitional epithelium along the lateral and ventrolateral aspects of the turbinates and were most prevalent in mice exposed to 0.5 and 1.0 ppm. However, these lesions were, in general, mild and without clinically apparent toxic effects. Focal atrophy was observed in the olfactory epithelium. Nasal lesions persisted with lifetime exposure but did not progress. In most instances, the severities of these lesions tended to be less than those of the corresponding exposure groups in the 2-yr studies, indicating that adaptation may have occurred for these particular lesions. The distribution of nasal lesions observed in the present studies is similar to those seen with shorter term exposures of rats and monkeys (20, 21, 24, 25, 28) . Lesions occurred in the cuboidal epithelium along the lateral walls, margins, and tips of the naso-and maxilloturbinates. In the present studies, despite chronic nasal toxicity, there was no evidence of nasal carcinogenesis.
The precise biochemical or molecular mechanisms of ozone toxicity are unclear. In the respiratory tract, ozone reaches the tissues only where the thickness of the mucus layer is less than 0.1 1 [Lm. A major fraction of ozone reacts with lipids in the surfactant layer of the lung. The underlying mechanism of toxicity has been attributed to its ability to cause oxidation of biomolecules either directly or via the formation of free radicals and reactive intermediates (aldehydes, hydrogen peroxides, ozonides) or by both processes (6, 29, 37, 38, 40) . Support for free radical mechanisms stems from reports of significant protective effects of antioxidants such as vitamin E (9, 14) and evidence that levels of protective antioxidant enzymes increase with increasing ozone exposure (3). Free radicals and reaction products cause tissue injury by peroxidation of membrane lipids, loss of functional groups and enzyme activities, alteration of membrane permeability and function, and the induction of inflammation (37, 40) .
Whereas the toxicity of ozone in the respiratory tract of animals and people has been well documented, few studies have attempted to characterize the carcinogenic potential of ozone. Ozone is mutagenic in Salmonella ty-phimurium (13, 49) . There are no reports linking ozone ( exposure to lung cancer in humans. However, ozone has 1 been reported to be carcinogenic or to enhance the car-« cinogenic process in mice (23, 33) . The mechanism of ozone-induced carcinogenesis is not clear but may be related to its ability to induce the production of reactive intermediates and free radicals that are known to damage a variety of biomolecules including DNA. There is substantial evidence suggesting that increased concentrations of reactive oxygen species and free radicals can both initiate and promote carcinogenesis (8, 27) . Ozone has been reported to produce DNA injury directly and indirectly through the production of hydroxyl radicals (49) . Recent molecular studies on lung neoplasms from mice exposed to ozone suggest that ozone may cause direct and/or indirect DNA damage in the K-ras proto-oncogene (46) .
In the present study, there was a trend toward increased incidences of lung neoplasms with increasing ozone exposure that differed between the sexes and between the 2-yr and lifetime studies. In the 2-yr study, the trend was most prominent in female mice exposed to 1.0 ppm, in which the incidence of alveolar/bronchiolar adenoma or carcinomas (combined) was significantly increased. In the lifetime study, there was a significant positive trend for carcinomas in male mice and for adenomas in female mice.
The lifetime study was included because there was an indication from a previous study that an increase in treatment-related lung neoplasms may develop after 2 yr of exposure (36) . In female mice, a carcinogenic effect for lung neoplasms was evident by 2 yr of exposure. In male mice, the marginal increase in the incidence of lung neoplasms at 2 yr and 30 mo could not be definitively attributed to ozone exposure. Therefore, the lifetime portion of the study was not critical to the overall interpretation of the results with respect to lung carcinogenicity.
The results indicate that prolonged exposure to ozone is carcinogenic in female mice; its carcinogenic potential in male mice is, however, uncertain. The reasons for the different carcinogenic responses between the sexes are also not certain. Evidence for carcinogenicity in female mice include (a) the site-specific occurrence of neoplasms in an organ in which ozone has significant exposure-related toxic effects, (b) an increase in the incidence of lung neoplasms in both the 2-yr and lifetime studies, and (c) a combined incidence of benign and malignant lung neoplasms in female mice that exceeded the historical range and approximately doubled the mean incidence in controls. In the companion animal study, a similar spectrum of nasal and pulmonary nonneoplastic lesions were observed in F-344 rats exposed to identical concentrations of ozone for 2 yr or for the lifetime of the animals (4). However, in contrast to mice, there was no evidence of carcinogenicity in rats.
The current study indicates that long-term exposure to relatively high concentrations of ozone can increase the incidence of lung neoplasms in B6C3F1 mice. Results also indicate that nonneoplastic toxic effects, with potential for adverse effects on human health, occur and persist in the nasal cavity and lung with prolonged exposure. In view of the potential for long-term human exposure, the jata presented here are critical for the assessment of potential human health risks associated with ozone exposure.
